Dr Jianjun Xu | Hepatobiliary Oncology and Cancer | Best Researcher Award

Dr Jianjun Xu | Hepatobiliary Oncology and Cancer | Best Researcher Award

Union Hospital, Tongii Medical | China

Author Profile

Scopus

Orcid id

🏥 Dr. Jianjun Xu: Pioneering Hepatobiliary Oncology Specialist

👨‍⚕️ Full Name: Jianjun Xu

🏅 Designation: Attending Doctor

🏨 Department:

  • Department of Hepatobiliary Surgery
  • Center for Liver Transplantation

🎓 Qualification: Doctor

🔬 Area of Specialization: Hepatobiliary Oncology and Cancer

💡 Sub Division: Oncology Therapeutics and Novel Approaches

🕒 Total Experience:

  • Work for 2 years
  • Doctor for 3 years
  • Master for 3 years
  • Bachelor for 5 years

 


🎓 Education

📚 2011-2016: Bachelor of Clinical Medicine, School of Medicine, Nanchang University.

🎓 2016-2019: Master of Surgery, Tongji Medical College, Huazhong University of Science and Technology.

🏫 2019-2022: Doctor of Surgery, Tongji Medical College, Huazhong University of Science and Technology.


🏥 Experience

🩺 July 2022 to Present: Attending Doctor at Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Wuhan 430022, China.


🔬 Contributions to Research, Innovations, and Extension Activities On Hepatobiliary Oncology and Cancer

Throughout his tenure, Dr. Jianjun Xu has made significant contributions to Tumor Research & Development, Innovations, and Extension Activities. Actively participating in research projects, he has advanced the understanding of tumor biology, therapeutic interventions, and patient care outcomes. Leveraging his expertise in hepatobiliary malignancies, Dr. Xu collaborates with interdisciplinary teams to identify novel biomarkers, therapeutic targets, and treatment modalities, aiming to improve patient outcomes and quality of life.

Dr. Xu has also been involved in innovative initiatives to translate research findings into clinical practice. By fostering partnerships with industry stakeholders, academic institutions, and healthcare providers, he has facilitated the development and implementation of cutting-edge technologies and treatment approaches in oncology.

In addition to his research endeavors, Dr. Xu actively engages in extension activities to disseminate knowledge and promote awareness of cancer prevention, early detection, and treatment options within the community. Through educational workshops, public seminars, and outreach programs, he empowers patients, caregivers, and healthcare professionals with the necessary information and resources to combat cancer effectively. His dedication to advancing cancer research, innovation, and community outreach underscores his commitment to making a meaningful impact in the fight against cancer.

NOTABLE PUBLICATION:

Assist Prof Zhe Xu | Foodborne osteogenic peptides | Best Researcher Award

Assist Prof Zhe Xu | Foodborne osteogenic peptides| Best Researcher Award

Dalian Minzu University | China

AUTHOR PROFILE

Scopus

EARLY ACADEMIC PURSUITS 🎓

Zhe Xu’s academic journey commenced with a Bachelor of Science degree in Food Science from Dalian Polytechnic University, China, from 2011 to 2015. This foundational period laid the groundwork for his future pursuits in the field of food science and technology. Following his undergraduate studies, he continued to pursue higher education, culminating in a Ph.D. in Food Science from the same institution, spanning from 2015 to 2020. These formative years provided Xu with a comprehensive understanding of food science principles, research methodologies, and a solid academic foundation for his subsequent endeavors.

PROFESSIONAL ENDEAVORS 🌟

Xu’s professional journey is characterized by a series of significant roles and experiences that have contributed to his growth and expertise in the field. From 2021 onwards, he has served as an Assistant Professor at the School of Life Science, Dalian Minzu University, China, where he has actively engaged in teaching, research, and academic leadership. Concurrently, he embarked on a postdoctoral position at the Institute of Bast Fiber Crops & Center of Southern Economic Crops, Chinese Academy of Agricultural Sciences, China, focusing on research related to food-derived functional factors. Additionally, since 2023, Xu has held the position of Visiting Professor at the University of Alberta, Canada, further expanding his global academic network and collaborations.

CONTRIBUTIONS AND RESEARCH FOCUS ON FOODBORNE OSTEOGENIC PEPTIDES📚

Xu’s research endeavors encompass a diverse range of topics within the realm of food science and technology. His primary focus lies in the screening and identification of osteogenic protein peptides from food sources, aiming to uncover potential therapeutic agents for bone health. Furthermore, he delves into the identification and activity mechanism analysis of food-derived functional factors, exploring their implications for human health and nutrition. Additionally, Xu investigates the digestive properties of food components in the gastrointestinal tract, shedding light on crucial aspects of digestion and nutrient absorption. Through his research, Xu contributes valuable insights to the field, addressing pressing challenges and advancing scientific knowledge.

IMPACT AND INFLUENCE 🌐

Xu’s contributions to the field of food science have left a notable impact on both academia and industry. His research findings have been disseminated through publications in reputable journals, presentations at international conferences, and collaborations with esteemed institutions worldwide. By elucidating the potential health benefits of food-derived bioactive compounds and unraveling the mechanisms underlying their physiological effects, Xu’s work has the potential to inform dietary recommendations, pharmaceutical development, and clinical practice, ultimately benefiting global health and well-being.

ACADEMIC CITATIONS 📖

Xu’s research output has garnered significant attention within the academic community, as evidenced by citations in peer-reviewed publications and scholarly discourse. His work serves as a foundational resource for researchers, educators, and practitioners in the field of food science, providing valuable insights and avenues for further exploration. Through his innovative approach and rigorous methodology, Xu has established himself as a respected figure in the academic landscape, contributing to the advancement of knowledge and understanding in his field.

LEGACY AND FUTURE CONTRIBUTIONS HIGHLIGHT 🚀

As Xu continues to navigate his academic and professional journey, his legacy is shaped by a commitment to excellence, innovation, and collaboration. With a steadfast dedication to advancing scientific knowledge and addressing global challenges in food science and technology, Xu’s future contributions hold the promise of transformative impact. Through continued research endeavors, mentorship of aspiring scholars, and engagement with diverse stakeholders, Xu aims to leave a lasting legacy that transcends disciplinary boundaries and fosters positive change in society.

NOTABLE PUBLICATION:

Prof Shengping Hou | Immunotherapy | Best Researcher Award

Prof Shengping Hou | Immunotherapy | Best Researcher Award

Beijing Tongren Hospital, Capital Medical University | China

AUTHOR PROFILE

Scopus

Orcid ID

EARLY ACADEMIC PURSUITS

Shengping Hou, Ph.D., began his academic journey at Sun Yat-sen University in China, where he obtained his Ph.D. in Ocular Immunology in 2009. His doctoral research laid the foundation for his future contributions to ocular immunology, particularly focusing on the genetic aspects of ocular diseases. Following his Ph.D., Dr. Hou furthered his expertise with a postdoctoral fellowship at the University of California, San Francisco, specializing in Ocular Stem Cell Biology, which he completed in 2016.

PROFESSIONAL ENDEAVORS

Dr. Hou’s professional career commenced at The First Affiliated Hospital of Chongqing Medical University, where he served as an Associate Professor from 2009 to 2015. He was later promoted to Professor, a position he held until 2023. During his tenure, he was also a key figure at the Chongqing Key Laboratory of Ophthalmology. In 2023, Dr. Hou transitioned to Beijing Tongren Hospital, where he now serves as the Director of the Beijing Institute of Ophthalmology and continues his professorship at Capital Medical University.

CONTRIBUTIONS AND RESEARCH FOCUS ON IMMUNOTHERAPY

Dr. Hou’s research has primarily centered on the genetic and immunological underpinnings of ocular diseases, particularly uveitis and Behcet’s disease. His work has involved extensive genetic studies, including the investigation of VKH syndrome and the role of complement component 4 copy number variants in ocular pathogenesis. His notable projects have been consistently supported by grants from the National Natural Science Foundation and other key R&D initiatives in China.

IMPACT AND INFLUENCE

Dr. Hou’s contributions have earned him significant recognition in the scientific community. He has been honored with several prestigious awards, including the First Prize for Achievement in Science and Technology from both Chongqing and the Chinese Health Ministry. His research findings have been widely disseminated through invited lectures and presentations at major international conferences, enhancing the understanding of genetic influences in ocular diseases.

ACADEMIC CITATIONS

Throughout his career, Dr. Hou has been an active member of the Chinese Ocular Immunology Society and has served as an ad hoc reviewer for several high-impact journals such as Nature Reviews Rheumatology, Advanced Science, and eBioMedicine. His work has been extensively cited by peers, reflecting the significant impact of his research on the field of ocular immunology.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. Hou’s legacy in the field of ophthalmology is marked by his dedication to uncovering the genetic mechanisms underlying ocular diseases. As the Director of the Beijing Institute of Ophthalmology, he continues to lead groundbreaking research and mentor the next generation of scientists. His future contributions are poised to further advance the understanding and treatment of ocular conditions, solidifying his status as a leading figure in ophthalmic research.

NOTABLE PUBLICATION: